E284 CMAJ| MARCH 11, 2019| VOLUME 191| ISSUE 10 more than the minimum needed
value of 35 000 daily units established by the currently available literature. 1 We decided to …

Patients receiving extracorporeal membrane oxygenation (ECMO) are at risk of circuit
thrombosis due to constant contact between blood and the extracorporeal components …

Background During venovenous extracorporeal membrane oxygenation (vvECMO), direct
thrombin inhibitors are considered by some potentially advantageous over unfractionated …

Background Extracorporeal membrane oxygenation (ECMO) have become more frequently
used in daily ICU practice, heparin-induced thrombocytopenia (HIT) is a rare but life …

Purpose: The purpose of this study was to evaluate the cost effectiveness of argatroban
compared to heparin during extracorporeal membrane oxygenation (ECMO) therapy …

Background: Heparin is the widely used anti-coagulation strategy for patients on
extracorporeal membrane oxygenation (ECMO). Nevertheless, heparin-induced …

Objectives Unfractionated heparin (UFH) is the commonly used anticoagulant to prevent
clotting of the ECMO circuit and thrombosis of the cannulated vessels. A side effect of UFH is …

OBJECTIVES: A significant proportion of patients with coronavirus disease 2019 requiring
venovenous extracorporeal membrane oxygenation at our institution demonstrated heparin …

Background Unfractionated heparin, administered during veno-arterial extracorporeal
membrane oxygenation to prevent thromboembolic events, largely depend on plasma …

Background Extracorporeal membrane oxygenation (ECMO) or pumpless extracorporeal
lung assist (pECLA) requires effective anticoagulation. Knowledge on the use of argatroban …